Antibodies, Viral/immunology; Antibodies, Viral/therapeutic use; Betacoronavirus/immunology; Coronavirus Infections/drug therapy; Coronavirus Infections/economics; Drug Costs; Pandemics/economics; Pneumonia, Viral/drug therapy; Pneumonia, Viral/economics; Administration, Inhalation; Animals; Antibodies, Viral/administration & dosage; Antibodies, Viral/economics; Betacoronavirus/genetics; COVID-19; Camelids, New World/immunology; Coronavirus Infections/immunology; Coronavirus Infections/prevention & control; Hemorrhagic Fever, Ebola/drug therapy; Hemorrhagic Fever, Ebola/immunology; Hemorrhagic Fever, Ebola/prevention & control; Humans; Immune Evasion/genetics; Pandemics/prevention & control; Pneumonia, Viral/immunology; Pneumonia, Viral/prevention & control; SARS-CoV-2; Single-Domain Antibodies/administration & dosage; Single-Domain Antibodies/economics; Single-Domain Antibodies/immunology; Single-Domain Antibodies/therapeutic use; Spike Glycoprotein, Coronavirus/immunology; United States; United States Food and Drug Administration/legislation & jurisprudence; COVID-19 Drug Treatment

Biotechnology; Medical research; SARS-CoV-2